Executive Management, Microbion Biosciences, cardiome pharma corp.#Cardiome #pharma #corp

Posted On Mar 3 2018 by

Executive Management Chairman CEO Mr. Lalji began his career with Merck Company. While at Merck, he led the infectious disease new product portfolio from the commercial perspective, with responsibility for products such as INVANZ, CANCIDAS and CRIXIVAN. Mr. Lalji was a key member of the team that ultimately led to the discovery of the triple cocktail for treating HIV infections. Mr. Lalji subsequently undertook responsibility for driving the global franchise strategies for Merck s two leading areas: cholesterol reducers and hypertension/heart failure treatments. His final role during his ten-year tenure at Merck was as an executive leading the worldwide osteoporosis …


CRME stock quote – Cardiome Pharma Corporation Ordinary Shares (Canada) price, cardiome pharma corp.#Cardiome #pharma #corp

Posted On Jan 16 2018 by

Cardiome Pharma Corporation Ordinary Shares (Canada) Quote & Summary Data Stock Details COMPANY NEWS FUNDAMENTALS Edit Symbol List Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. Don’t know the stock symbol? Use the Symbol Lookup tool. Alphabetize the sort order of my symbols Symbol Lookup Investing just got easier Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow. “Best Ask” is the lowest price currently being …


Raptor Pharmaceutical Corp #generic #pharma

Posted On Dec 2 2017 by

#raptor pharma # Traders Salivating For Action In Raptor Pharma: Here Are The Facts Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover chatter. Reuters said on April 6 Raptor has consulted with investment bankers and financial advisers to explore a potential sale. On Thursday, Bloomberg reported Retrophin, the company founded by Martin Shkreli, was said to be considering a takeover of Raptor Pharmaceutical. Raptor s …


Here s Why Raptor Pharmaceuticals Corp #biotechnology #industry

Posted On Nov 15 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Here s Why Raptor Pharmaceuticals Corp #marketing #pharmaceuticals

Posted On Sep 8 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Acxiom Lets Consumers See Data It Collects – The New York Times #data-mining #and #database #marketing,acxiom #corp,privacy,consumer #behavior,computer #security,advertising #and #marketing,federal #trade #commission,center #for #digital #democracy

Posted On Aug 14 2017 by

# Acxiom Lets Consumers See Data It Collects Scott Howe, chief of Acxiom, displayed his own information last week to demonstrate the company s consumer data portal. Credit Jacob Slaton for The New York Times Aboutthedata.com, a Web site introduced on Wednesday by a leading marketing technology firm called the Acxiom Corporation, is offering individual consumers a glimpse of some of the details the company has collected about them. Visitors who log in to the site may review many seemingly innocuous facts, such as whether someone in their household owns a dog or a cat, or is interested in jogging …


Stock trade online #ibm, #ibm #analyst #estimates, #ibm #earnings #estimates, #ibm #share #estimates, #ibm #analyst #recommendations, #ibm #ratings, #international #business #machines #corp. #analyst #estimates, #international #business #machines #corp. #earnings #estimates, #international #business #machines #corp. #analyst #recommendations, #international #business #machines #corp. #analyst #ratings

Posted On Aug 11 2017 by

# International Business Machines Corp. Jul. 19, 2017 at 5:14 p.m. ET by Victor Reklaitis U.S. stock-market indexes closed firmly higher Wednesday, with all of the main equity benchmarks notching records, as buying appetite resumed on Wall Street. The Dow Jones Industrial Average closed up 0.3% higher at 21,640, as big gains in shares of Boeing Co. and UnitedHealth Group Inc. –bouncing back from Tuesday s selling–helped to more than offset a 4.2% tumble in shares of International Business Machines Corp. which disappointed investors in second-quarter sales. IBM cut about 40 points from the price-weighted Dow, but the gauge still …


Raptor Pharmaceutical Corp #diamond #pharma

Posted On Aug 9 2017 by

#raptor pharma # Traders Salivating For Action In Raptor Pharma: Here Are The Facts Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover chatter. Reuters said on April 6 Raptor has consulted with investment bankers and financial advisers to explore a potential sale. On Thursday, Bloomberg reported Retrophin, the company founded by Martin Shkreli, was said to be considering a takeover of Raptor Pharmaceutical. Raptor s …


Here s Why Raptor Pharmaceuticals Corp #pharma #iq

Posted On Aug 9 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …


Raptor Pharmaceutical Corp #generic #drug #company

Posted On Aug 2 2017 by

#raptor pharma # Traders Salivating For Action In Raptor Pharma: Here Are The Facts Raptor Pharmaceutical Corp. (NASDAQ: RPTP ) is a bio-pharmaceutical company that focuses on the development of treatment for people affected by various diseases, including nephropathic cystinosis in adults and children. The stock was seeing some heavy buying action earlier this week on takeover chatter. Reuters said on April 6 Raptor has consulted with investment bankers and financial advisers to explore a potential sale. On Thursday, Bloomberg reported Retrophin, the company founded by Martin Shkreli, was said to be considering a takeover of Raptor Pharmaceutical. Raptor s …